Inhibitor of apoptosis proteins in pediatric leukemia : molecular pathways and novel approaches to therapy
- Sprache
-
Englisch
- Identifier
-
1081306076
Thema
Krebs; Onkologie
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Ähnliche Objekte (12)
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Targeting apoptosis signaling in pancreatic cancer
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
Small molecule inhibitors sensitize neuroblastoma cells for chemotherapeutic drug-induced apoptosis
Alternative cell death pathways and cell metabolism
Evasion of apoptosis as a cellular stress response in cancer
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis
Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Targeting apoptosis signaling in pancreatic cancer
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
Small molecule inhibitors sensitize neuroblastoma cells for chemotherapeutic drug-induced apoptosis
Alternative cell death pathways and cell metabolism
Evasion of apoptosis as a cellular stress response in cancer
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis
Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Targeting apoptosis signaling in pancreatic cancer
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
Small molecule inhibitors sensitize neuroblastoma cells for chemotherapeutic drug-induced apoptosis
Alternative cell death pathways and cell metabolism
Evasion of apoptosis as a cellular stress response in cancer
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis
Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation